期刊文献+

术前合并亚临床甲状腺功能减退症对甲状腺乳头状癌病人预后影响研究

Relationship between preoperative combined subclinical hypothyroidism and prognosis of papillary thyroid carcinoma
原文传递
导出
摘要 目的比较甲状腺乳头状癌术前合并亚临床甲状腺功能减退症的病人和甲状腺功能正常病人的病理学特征和预后差异。方法选取2005年1月至2007年12月间在第二军医大学长征医院行甲状腺乳头状癌根治术的656例病人,比较70例术前合并亚临床甲状腺功能减退症病人和514例甲状腺功能正常病人的各项临床病理因素,并对有差异因素进行二项Logistic多元回归分析。结果在肿瘤大小、是否侵犯包膜及多灶性方面,合并亚临床甲状腺功能减退症的病人和甲状腺功能正常的病人之间的差异无统计学意义,但合并亚临床甲状腺功能减退症的病人较甲状腺功能正常的病人的淋巴结转移率明显降低(8.6%vs.21.8%,P=0.068)结论术前亚临床甲状腺功能减退症TSH升高不能独立预测甲状腺乳头状癌的预后和肿瘤的侵袭性。 Objective To assess the difference between preoperative subclinical hypothyroidism and euthyroidism on prognosis and clinicopathotogical features of papillary thyroid carcinoma (PTC). Methods A total of 656 patients underwent surgery for PTC between January 2005 and December 2007 in Chang Zheng Hospital Affiliated to Second Military Medical University was enrolled in the study. All the clinical pathological factors between 70 patients with preoperative subclinical hypothyroidism and 514 patients with euthyroidism before the operation were compared. The difference factors were analyzed by multivariate logistic regression analysis. Results No significant difference was observed in tumour size, extrathyroidal extension and multifocality between subclinical hypothyroidism and euthyroid patients. But metastatic rate of lymph nodes in patients with subclinical hypothyroidism was less than that in euthyroid patients (8.6% vs. 21.8%, P=0.068). Conclusion Subclinical hypothyroidism with elevated TSH is not an independent predictor of tumour aggressiveness and poor prognosis in PTC.
出处 《中国实用外科杂志》 CSCD 北大核心 2014年第6期549-551,共3页 Chinese Journal of Practical Surgery
关键词 甲状腺乳头状癌 亚临床甲状腺功能减退症 papillary thyroid carcinoma subclinical hypothyroidism
  • 相关文献

参考文献13

  • 1Hercbergs A, Leith JT. Spontaneous remission of metastatic lung cancer following myxedema coma-an apoptosis-related phenom- enon [ J ]. J Natl Cancer Inst, 1993,85(16): 1342-1343.
  • 2Hoffman DA, McConahey WM, Brinton LA, et al. Breast cancer in hypothyroid women using thyroid supplements [J].JAMA , 1984,251(5):616-619.
  • 3Chmidinger M, Vogl UM, Bojic M, et al. Hypothyroidism in pa- tients with renal cell carcinoma: blessing or curse [J].Cancer, 2011,117(3):534-544.
  • 4Cristofanilli M, Yamamura Y, Kau SW, et al.Thyroid hormone and breast carcinoma, Primary hypothyroidism is associated with a reduced incidence of primary breast carcinoma [J].Cancer , 2005,103(6): 1122-1128.
  • 5Hercbergs A. The thyroid gland as an intrinsic biologic re- sponse-modifier in advanced neoplasia-a novel paradigm [J]. InVivo, 1996,10(2):245-247.
  • 6Surks MI, Ortiz E, Daniels GH, et at. Subclinical thyroid dis- ease : scientific review and guidelines for diagnosis and manage- ment [J].JAMA , 2004,291 (2) : 228-238.
  • 7Canaris GJ, Manowits NR, Mayor G, et al.The Colorado thyroid disease prevalence study [J], Arch Intern Med , 2000,160(4): 526-534.
  • 8Ahn D, Heo SJ, Park JH, er al. Clinical relationship between Hashimoto' s thyroiditis and papillary thyroid cancer [J].Acta Oncol , 2011,50(8) : 1228-1234.
  • 9Suk Kyeong Kim, Kee-Ho Song, So Duk Lira, et al. Clinical and pathological features and the BRAF(V600E) mutation in patients with papillary thyroid carcinoma with and without concurrent hashimoto thyroiditis[J].Thyroid ,2009, 19(2),137-141.
  • 10Hercbergs AH, Ashur-Fabian O, Garfield D. Thyroid hormones and cancer: clinical studies of hypothyroidism in oncology [J ]. Curr Opin Endocrinol Diabetes Obes , 2010,17(6):432-436.

二级参考文献10

  • 1Enewold L, et al. Rising thyroid cancer incidence in the United States by demographic and tumor characteristics, 1980-2005 [J~. Cancer Epidemiol Biomarkers Prey, 2009,18(3): 784-791.
  • 2Wang, W,et al Clonal analysis of bilateral, recurrent, and meta- static papillary thyroid carcinom [J] as. Hum Pathol,2010. 41(9): p. 1299-309.
  • 3Hwang E,et al. Bilateral papillary thyroid cancer and associated histopathologic findings [J]. J Otolaryngol Head Neck Surg, 2010, 39(3): 284-287.
  • 4Connor MP, Wells D, Schmalbach CE.Variables predictive of bi- lateral occult papillary microcarcinoma following total thyroidec- tomy[J]. Otolaryngol Head Neck Surg, 2011, 144(2):210-215.
  • 5Mercante G,et al. Prognostic factors affecting neck lymph node recurrence and distant metastasis in papillary microcarcinoma of the thyroid: results of a study in 445 patients [J ]. Thyroid, 2009, 19(7): 707-716.
  • 6Lee YS, et al. Clinical Implications of Bilateral Lateral Cervical Lymph Node Metastasis in Papillary Thyroid Cancer: A Risk Factor for Lung Metastasis [J]. Ann Surg Oncol, 2011, 18(12): 3486-3492.
  • 7Spriano G,et al. Pattern of regional metastases and prognostic factors in differentiated thyroid carcinoma [J]. Acta Otorhino- laryngol Ital, 2009, 29(6): 312-316.
  • 8向俊,吴毅.甲状腺癌临床诊治新特点(附572例临床分析)[J].中国实用外科杂志,2008,28(5):365-367. 被引量:107
  • 9刘春萍,明洁,石岚,李治,黄韬.分化型甲状腺癌手术治疗方法的探讨[J].中国普通外科杂志,2008,17(5):409-411. 被引量:48
  • 10于晓会,单忠艳.甲状腺结节病因学与流行病学再认识[J].中国实用外科杂志,2010,30(10):840-842. 被引量:96

共引文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部